Author:
Bressler Neil M.,Kaiser Peter K.,Do Diana V.,Nguyen Quan Dong,Park Kyu Hyung,Woo Se Joon,Sagong Min,Bradvica Mario,Kim Mercy Yeeun,Kim Seungkee,Sadda SriniVas R.
Reference190 articles.
1. Biosimilars: impact of biologic product life cycle and European experience on the regulatory trajectory in the United States;Ahmed;Clin Ther,2012
2. Switching among biosimilars: a review of clinical evidence;Allocati;Front Pharm,2022
3. Alvotech Swiss. Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE) 2023 [Available from: 〈https://clinicaltrials.gov/ct2/show/NCT05155293〉 (Last accessed February 07, 2024).
4. American Academy of Ophthalmology - Board of Trustees. The Use of Biosimilars in Ophthalmic Practice 2022 [Available from: 〈https://www.aao.org/education/clinical-statement/use-of-biosimilars-in-ophthalmic-practice〉 (Last accessed March 09, 2023).
5. American Society of Retina Specialists. 2022 Global Trends in Retina Survey 2022 [Available from: 〈https://www.asrs.org/content/documents/2022-asrs-global-trends-in-retina-survey.pdf〉 (Last accessed March 20, 2023).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献